Y-mAbs Therapeutics Inc
General ticker "YMAB" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $455.1M
Y-mAbs Therapeutics Inc follows the US Stock Market performance with the rate: 14.1%.
Estimated limits based on current volatility of 4.2%: low 8.07$, high 8.78$
Factors to consider:
- Current price 15.0% above estimated high
- Earnings for 15 months up through Q1 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2022-12-31 to 2024-12-30
- 2022-12-31 to 2023-12-31 estimated range: [3.05$, 8.16$]
- 2023-12-31 to 2024-12-30 estimated range: [2.85$, 7.05$]
Financial Metrics affecting the YMAB estimates:
- Negative: Non-GAAP EPS, $ of -2.18 <= 0.10
- Negative: Operating profit margin, % of -59.23 <= 1.03
- Negative: Operating cash flow per share per price, % of -27.25 <= 2.35
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of -21.66 <= 3.85
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: Interest expense per share, $ of 0.02 <= 0.14
Short-term YMAB quotes
Long-term YMAB plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $34.90MM | $65.27MM | $84.82MM |
| Operating Expenses | $150.33MM | $160.08MM | $110.49MM |
| Operating Income | $-115.43MM | $-94.81MM | $-25.67MM |
| Non-Operating Income | $60.16MM | $-0.76MM | $4.81MM |
| Interest Expense | $1.85MM | $0.76MM | $0.00MM |
| R&D Expense | $93.25MM | $91.57MM | $54.22MM |
| Income(Loss) | $-55.27MM | $-95.57MM | $-20.87MM |
| Taxes | $0.00MM | $0.00MM | $0.56MM |
| Profit(Loss) | $-55.27MM | $-95.57MM | $-21.43MM |
| Stockholders Equity | $180.11MM | $109.22MM | $100.98MM |
| Inventory | $5.51MM | $6.70MM | $5.07MM |
| Assets | $212.78MM | $141.46MM | $127.87MM |
| Operating Cash Flow | $-102.56MM | $-75.92MM | $-27.23MM |
| Capital expenditure | $0.97MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $61.04MM | $0.04MM | $0.01MM |
| Financing Cash Flow | $108.31MM | $0.08MM | $0.10MM |
| Earnings Per Share* | $-1.30 | $-2.20 | $-0.49 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.